BeOne Medicines
Michelle Tan is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as General Manager for South East Asia at BeiGene since March 2022. Prior to this role, Michelle worked as Regional Marketing Director for Oncology at Merck, overseeing marketing strategies across Japan, China, Australia, and Korea from March 2017 to March 2022. Previously, at Pfizer, Michelle held multiple leadership roles in the Vaccines sector, including Cluster Lead and Head of Sales, managing significant teams and responsibilities across Taiwan, Hong Kong, Malaysia, and Singapore. Michelle's career also includes key positions at Novartis, where responsibilities encompassed marketing for Transplant and Oncology products, and early roles at Pfizer focused on product management and business operations in Oncology and Ophthalmology. Educational qualifications include an MBA and a Hons Degree in Biochemistry and Molecular Biology from the University of Leeds, alongside a Diploma in Biotechnology from Ngee Ann Polytechnic.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.